Release Date: 22/04/16 17:54 Summary: Announcement in relation to Takeover Bid-BRS.AX Price Sensitive: No Download Document 85.45KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%